A significant advance in HIV-1 vaccine research has been reported in Nature Immunology.
A new path to an HIV-1 vaccine emerges from the V3 loop
A significant advance in HIV-1 vaccine research has been reported in Nature Immunology. Scientists have identified a new type of neutralizing antibody that targets the V3 loop of the HIV-1 envelope protein. Crucially, this antibody does not depend on the presence of a specific sugar molecule (the Asn332 glycan) to bind and neutralize the virus.